Birth weight affects final height in patients treated for growth hormone deficiency

被引:11
作者
Cacciari, E [1 ]
Zucchini, S [1 ]
Cicognani, A [1 ]
Pirazzoli, P [1 ]
Balsamo, A [1 ]
Salardi, S [1 ]
Cassio, A [1 ]
Pasini, A [1 ]
Gualandi, S [1 ]
机构
[1] Univ Bologna, Clin Paediat 1, I-40138 Bologna, Italy
关键词
D O I
10.1046/j.1365-2265.1999.00875.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE Birth weight influences both postnatal growth and the initial response to GH therapy in GH-deficient subjects, but its relationship to final height is uncertain. Therefore, we examined final height results in a group of subjects treated for GH deficiency who were born small, appropriate or large for gestational age (GA). DESIGN Retrospective study. PATIENTS 108 GH-treated patients (age at diagnosis 11.1 +/- 2.0 years) affected by idiopathic and isolated GH deficiency (peak <8 mu g/l after pharmacological and/or nocturnal mean GH concentration less than or equal to 3.3 mu g/l) were examined. Twenty-four had a birth weight <3rd centile (2300 g +/- 268 - small for GA), 77 between the 3rd and 90th centile (3216 g +/- 317: appropriate for GA) and 7 above the 90th centile (4193g +/- 143: large for GA). MEASUREMENTS All subjects reached final height (growth velocity < 0.5 cm/year in the last year of treatment) after hGH treatment (range 33-96 months) at a dose of 20U/m(2)/week. The 3 groups of subjects started therapy at a similar height for chronological and bone age. RESULTS Final height in the small for GA group was -1.71 +/- 0.93 standard deviation score (SDS), significantly lower than that of both appropriate (-1.14 +/- 0.83 (P <0.01)) and large (-0.70 +/- 0.89 (P <0.01)) for GA groups. Similarly, the small for GA group had a significantly lower height SDS increment from the start of therapy to adult height (0.54 +/- 0.84) than both the appropriate (0.99 +/- 0.78 (P <0.05)) and the large (1.49 +/- 0.84 (P <0.01)) for GA groups. The percentage of subjects with final height above target height was significantly different in the 3 groups: 21% for the small, 38% for the appropriate and 71% for the large for GA groups (P <0.05). In the whole group of patients there was a positive correlation between birth weight and final height (r = 0.38; P <0.0001). CONCLUSIONS The present study showed that our patients, affected by isolated and idiopathic GH deficiency but with different birth weights, despite starting treatment with a similar height and bone age delay, had different auxological outcomes. It seems, therefore, that final height is strongly influenced by birth weight which penalizes the smaller newborns and assists the larger ones.
引用
收藏
页码:733 / 739
页数:7
相关论文
共 26 条
[1]   Birth weight influences the initial response to growth hormone treatment in growth hormone-insufficient children [J].
Achermann, JC ;
Hamdani, K ;
Hindmarsh, PC ;
Brook, CGD .
PEDIATRICS, 1998, 102 (02) :342-345
[2]  
Albertsson-Wikland K, 1989, Acta Paediatr Scand Suppl, V349, P35
[3]   RESPONSE TO GROWTH-HORMONE THERAPY IN PATIENTS WITH GROWTH-HORMONE DEFICIENCY WHO AT BIRTH WERE SMALL OR APPROPRIATE IN SIZE FOR GESTATIONAL-AGE [J].
BALSAMO, A ;
TASSONI, P ;
CASSIO, A ;
COLLI, C ;
TASSINARI, D ;
CICOGNANI, A ;
CACCIARI, E .
JOURNAL OF PEDIATRICS, 1995, 126 (03) :474-477
[4]  
BINKIN NJ, 1988, PEDIATRICS, V82, P828
[5]   SPONTANEOUS 24-HOUR GROWTH-HORMONE PROFILES IN PREPUBERTAL SMALL-FOR-GESTATIONAL-AGE CHILDREN [J].
BOGUSZEWSKI, M ;
ROSBERG, S ;
ALBERTSSONWIKLAND, K .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1995, 80 (09) :2599-2606
[6]   PITFALLS IN DIAGNOSING IMPAIRED GROWTH-HORMONE (GH) SECRETION - RETESTING AFTER REPLACEMENT THERAPY OF 63 PATIENTS DEFINED AS GH DEFICIENT [J].
CACCIARI, E ;
TASSONI, P ;
PARISI, G ;
PIRAZZOLI, P ;
ZUCCHINI, S ;
MANDINI, M ;
CICOGNANI, A ;
BALSAMO, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 74 (06) :1284-1289
[7]   VALUE AND LIMITS OF PHARMACOLOGICAL AND PHYSIOLOGICAL TESTS TO DIAGNOSE GROWTH-HORMONE (GH) DEFICIENCY AND PREDICT THERAPY RESPONSE - FIRST AND 2ND RETESTING DURING REPLACEMENT THERAPY OF PATIENTS DEFINED AS GH DEFICIENT [J].
CACCIARI, E ;
TASSONI, P ;
CICOGNANI, A ;
PIRAZZOLI, P ;
SALARDI, S ;
BALSAMO, A ;
CASSIO, A ;
ZUCCHINI, S ;
COLLI, C ;
TASSINARI, D ;
TANI, G ;
GUALANDI, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1663-1669
[8]   Final height of patients treated for isolated GH deficiency: Examination of 83 patients [J].
Cacciari, E ;
Cicognani, A ;
Pirazzoli, P ;
Zucchini, S ;
Salardi, S ;
Balsamo, A ;
Cassio, A ;
Pasini, A ;
Carla, G ;
Tassinari, D ;
Gualandi, S .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 137 (01) :53-60
[9]   DOSE-DEPENDENT CATCH-UP GROWTH AFTER 2 YEARS OF GROWTH-HORMONE TREATMENT IN INTRAUTERINE GROWTH-RETARDED CHILDREN [J].
CHATELAIN, P ;
JOB, JC ;
BLANCHARD, J ;
DUCRET, JP ;
OLIVIER, M ;
SAGNARD, L ;
VANDERSCHUERENLODEWEYCKX, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06) :1454-1460
[10]   Short stature associated with intrauterine growth retardation: Final height of untreated and growth hormone-treated children [J].
Coutant, R ;
Carel, JC ;
Letrait, M ;
Bouvattier, C ;
Chatelain, P ;
Coste, J ;
Chaussain, JL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04) :1070-1074